Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

EOS imaging Announces New Sale into Carolinas HealthCare System

EOS imaging
Posted on: 13 Sep 16

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the sale of an EOS system to the Carolinas HealthCare System. The system will be located at a dedicated imaging center in Carolina HealthCare’s Morehead Medical Plaza campus in Charlotte, NC. It will be available for pediatric and adult patients in the Carolinas HealthCare System, including those served at the Levine Children's Hospital, which is also located in the Morehead Medical Plaza. The Levine Children’s Hospital was named a Best Children’s Hospital by U.S. News & World Report in orthopedics1.

Carolinas HealthCare System is one of the leading healthcare organizations in the Southeast and one of the most comprehensive systems in the country. The organization includes more than 900 care locations and 7,500 beds throughout North and South Carolina.

Marie Meynadier, CEO of EOS imaging, said, “We are pleased that the unique benefits of the EOS system and services will soon be available to patients in the North and South Carolina area. Adoption by such a prestigious group further validates our technology. In addition, this sale marks the entry into another large hospital network in the U.S., which further expands patient access to the EOS technology and provides incremental growth potential within the hospital network.”

For more information, please visit

EOS imaging has been chosen to be included in the new EnterNext© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI

About EOS imaging

EOS imaging designs, develops, and markets EOS®, an innovative medical imaging system dedicated to osteoarticular pathologies and orthopedics, as well as associated solutions. The Company is authorized to market in 51 countries, including the United States, Japan, China, and the European Union. The Group posted 2015 revenues of €21.8 million and employs 122 people. The Group is based in Paris and has five subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.


View source version on

Business Wire

Last updated on: 13/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.